Migranal (Degranol; list a) - antineoplastic. Applied for the treatment of Hodgkin's lymphoma, chronic leukaemia (chronic myelosis and lymphedemas), and when retikulosarkomatose, multiple myeloma, true polycythemia.
The injected dose (adults) 0,05-0,1 g 1 time in 2 days; in the course of 0.6-0.8 g systematic monitoring of blood picture. The release form: powder in sealed to 0.05 g; solutions are ex tempore of the izotonicescom solution of sodium chloride. Cm. also Antitumor agents.